USE OF MSCT EXAMINATION IN DIFFUSE LIVER DISEASES
Article Sidebar
Main Article Content
Abstract:
More than 350 million people worldwide are infected with hepatitis viruses. Each year, millions of people are newly infected with viruses causing liver diseases, including hepatitis B and hepatitis C, leading to life-threatening conditions. Liver cirrhosis and hepatocellular carcinoma are consequences of chronic hepatitis B and C infections.
Article Details
How to Cite:
Sharipov , A. ., Raxmonova , U. ., Koli , V., & Kalash , D. (2024). USE OF MSCT EXAMINATION IN DIFFUSE LIVER DISEASES. Young Scientists, 2(10), 114–121. Retrieved from https://in-academy.uz/index.php/yo/article/view/30321
References:
"Hepatitis C: The Silent Epidemic" by Lucinda K. Porter
"Hepatitis B and C: Management and Treatment" by Geoffrey Dusheiko
"Hepatitis C: A Complete Guide for Patients and Families" by Paul J. Thuluvath
"Hepatitis Viruses: Molecular Biology and Pathogenesis" by Seng-Lai Tan
"Hepatitis C Virus: From Molecular Virology to Antiviral Therapy" by Ralf Bartenschlager and Charles M. Rice